Agios Pharmaceuticals, Inc. (LON:0HB0)

Agios Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 20, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,596	1,497	977	1,280	1,318	2,198
Market Cap Growth	53.18%	53.18%	-23.69%	-2.87%	-40.02%	-10.83%
Enterprise Value	429	219	352	504	360	1,937
Last Close Price	27.48	26.32	17.50	25.51	24.92	32.40
PE Ratio	2.97	2.78	-	-	1.11	-
PS Ratio	51.35	51.35	46.40	108.35	-	-
PB Ratio	1.22	1.22	1.53	1.40	1.38	7.51
P/TBV Ratio	1.22	1.22	1.53	1.40	1.38	7.51
EV/Sales Ratio	14.88	7.51	16.69	42.61	-	-
EV/FCF Ratio	-1.37	-	-	-	-	-
Debt / Equity Ratio	0.04	0.04	0.09	0.08	0.08	0.26
Asset Turnover	0.03	0.03	0.02	0.01	-	-
Inventory Turnover	13.08	13.08	21.65	-	-	-
Quick Ratio	11.06	11.06	11.49	12.54	17.17	6.07
Current Ratio	11.90	11.90	12.27	13.30	17.79	6.74
Return on Equity (ROE)	57.29%	57.29%	-36.83%	-19.37%	-42.15%	-63.33%
Return on Assets (ROA)	-20.47%	-20.47%	-22.49%	-18.17%	-20.65%	-24.08%
Return on Capital (ROIC)	-21.45%	-21.45%	-23.65%	-18.88%	-24.98%	-33.35%
Earnings Yield	33.71%	35.95%	-28.29%	-15.02%	89.89%	-10.91%
FCF Yield	-19.59%	-20.89%	-23.87%	-20.38%	-23.14%	-10.16%
Buyback Yield / Dilution	-4.02%	-4.02%	-1.57%	9.36%	12.39%	-15.01%
Total Shareholder Return	-4.02%	-4.02%	-1.57%	9.36%	12.39%	-15.01%

Source: S&P Capital IQ. Standard template. Financial Sources.